{
    "organizations": [],
    "uuid": "ecf20bfc9449de87196d2cbe501806130d6ddd5b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-matinas-biopharma-holdings-reports/brief-matinas-biopharma-holdings-reports-q1-loss-per-share-of-0-05-idUSASC0A1DL",
    "ord_in_thread": 0,
    "title": "BRIEF-Matinas Biopharma Holdings Reports Q1 Loss Per Share Of $0.05",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 10 (Reuters) - Matinas BioPharma Holdings Inc:\n* MATINAS BIOPHARMA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE\n* Q1 LOSS PER SHARE $0.05 * MATINAS - EXPECTS TO COMMENCE PIVOTAL PHASE 2 ADAPTIVE-DESIGNED STUDY FOR MAT2203 FOLLOWING ITS NEXT INTERACTION WITH FDA IN FIRST HALF OF 2019\n* ENDED QUARTER WITH CASH AND CASH EQUIVALENTS OF APPROXIMATELY $4.3 MILLION\n* COMPANY BELIEVES THAT CASH ON HAND IS SUFFICIENT TO FUND OPERATIONS INTO SEPTEMBER 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T19:13:00.000+03:00",
    "crawled": "2018-05-11T12:48:50.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "matinas",
        "biopharma",
        "holding",
        "inc",
        "matinas",
        "biopharma",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "corporate",
        "update",
        "q1",
        "loss",
        "per",
        "share",
        "matinas",
        "expects",
        "commence",
        "pivotal",
        "phase",
        "study",
        "mat2203",
        "following",
        "next",
        "interaction",
        "fda",
        "first",
        "half",
        "ended",
        "quarter",
        "cash",
        "cash",
        "equivalent",
        "approximately",
        "million",
        "company",
        "belief",
        "cash",
        "hand",
        "sufficient",
        "fund",
        "operation",
        "september",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}